Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
Neumayer
H H
HH
Department of Nephrology, Friedrich-Alexander University Erlangen-Nürnberg, Germany.
Färber
L
L
Haller
P
P
Kohnen
R
R
Maibücher
A
A
Schuster
A
A
Vollmar
J
J
Waiser
J
J
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014184:Transplantation, Homologous; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase